- Pfizer considers cost cuts as demand for COVID products falls Reuters
- Pfizer unveils potential cost-cutting measure on low COVID sales FiercePharma
- Pfizer COVID business declines as demand for boosters lag Axios
- Merck stock up on Q2 earnings beat, Pfizer revenue declines on falling COVID vaccine demand Yahoo Finance
- Pfizer misses revenue estimates, says it may cut costs if Covid product sales continue to disappoint CNBC
- View Full Coverage on Google News
Source link